Cubist Pharmaceuticals

When Will They Learn? 4 Huge Biotech Blowups
Motley Fool
Thu, 03/29/18 - 09:24 pm
biotech
AstraZeneca
ZS-9
drug manufacturing
Alexion
Synageva
Merck
Cubist Pharmaceuticals
AbbVie
Rova-T
Stemcentrx
U.S. Supreme Court rejects patent appeal over Cubicin drug
Yahoo/Reuters
Tue, 05/31/16 - 11:01 am
Supreme Court
Cubicin
patents
generics
antibiotics
Cubist Pharmaceuticals
Merck
Merck Completes Tender Offer to Acquire Cubist
Yahoo
Wed, 01/21/15 - 09:18 am
Merck
M&A
Cubist Pharmaceuticals
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
4 Potential Blockbuster Drugs The FDA Just Approved
Investors.com
Fri, 12/26/14 - 10:11 pm
Bristol-Myers Squibb
Opdivo
Merck
Cubist Pharmaceuticals
Zerbaxa
AstraZeneca
Lynparza
Novo Nordisk
Saxenda
Year in review: The biggest stories in biotech in 2014
Bizjournals.com
Fri, 12/26/14 - 09:51 am
biotech
Merck
M&A
Cubist Pharmaceuticals
Idenix
Covidien
Medtronic
Gilead Sciences
Shire
AbbVie
drug pricing
FDA approves Cubists' drug for antibiotic-resistant bacteria
Yahoo/Reuters
Sat, 12/20/14 - 10:12 am
Cubist Pharmaceuticals
Zerbaxa
antibiotics
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
Motley Fool
Wed, 10/22/14 - 08:37 am
Cubist Pharmaceuticals
Sivextro
Cubicin
anti-infectives
Zerbaxa
Cubist extends superbug R&D to Europe
Pharmaphorum
Thu, 09/18/14 - 09:27 am
Cubist Pharmaceuticals
Europe
R&D
antibiotics
antibiotic resistance
Cubist Battling Superbugs Offers Remedy for J&J: Real M&A
Bloomberg
Mon, 08/18/14 - 11:04 am
JNJ
M&A
Cubist Pharmaceuticals
antibiotics
superbugs
Investing to Fight Toilet and Elevator Superbugs
Motley Fool
Sun, 07/20/14 - 09:19 am
Durata Therapeutics
Cubist Pharmaceuticals
3 Biotech Stocks with Jaw-Dropping Growth Potential
Motley Fool
Sun, 06/29/14 - 10:01 am
Cubist Pharmaceuticals
NPS Pharmaceuticals
Flamel
Cubist and Durata Heat Up Antibiotic Market
Motley Fool
Tue, 06/24/14 - 09:51 am
Cubist Pharmaceuticals
Durata Therapeutics
antibiotics
Dalvance
Sivextro
ceftolozane/tazobactam
Cubist Sivextro sales to benefit from lack of warnings, says JMP Securities
The Fly on the Wall
Mon, 06/23/14 - 12:53 pm
Sivextro
antibiotics
Cubist Pharmaceuticals
FDA approves Cubist drug to treat acute skin infections
Yahoo/Reuters
Fri, 06/20/14 - 08:05 pm
FDA
Cubist Pharmaceuticals
antibiotics
Sivextro
As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St
Fri, 06/20/14 - 12:31 pm
antibiotic resistance
antibiotics
Cubist Pharmaceuticals
Durata
Insmed
Medicines Company
Tetraphase Pharmaceuticals
Cubist Readies For Takeoff With New Antibiotic Launch
Investors.com
Thu, 06/19/14 - 05:39 pm
antibiotics
Cubist Pharmaceuticals
Sivextro
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
Mon, 06/9/14 - 11:04 am
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Superbug Researchers Wait on Future of AstraZeneca Drugs
Bloomberg
Fri, 05/23/14 - 07:02 am
AstraZeneca
Pfizer
superbugs
antibiotics
Cubist Pharmaceuticals
drug-resistant bacteria
Cubist gram-negative antibiotic data supports approval, says JMP Securities
The Fly on the Wall
Tue, 05/13/14 - 09:52 am
Cubist Pharmaceuticals
antibiotics
gram-negative bacteria

Pages